// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1151 Abstracts

Glomerular Disease in Women

Kate Wiles - International Society of Nephrology (ISN) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Acute Kidney Injury in Pregnancy: The Changing Landscape for the 21st Century

Swati Rao - International Society of Nephrology (ISN) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

N/A

Hydroxychloroquine

A RARE EXPERIENCE WITH RHUPUS: EFFECT OF RITUXIMAB

S. BHUWANIA - International Society of Nephrology (ISN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Rheumatoid arthritis

Hydroxychloroquine

Eculizumab Responsive Atypical Hemolytic Uremic Syndrome Triggered by a Multisystem Lupus Flare

BushraSyed - American Society of Nephrology (ASN) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

Hydroxychloroquine

Drug Induced Lupus Nephritis in Psoriasis Secondary to Adalimumab Use

GurleenKaur - American Society of Nephrology (ASN) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Chondrodysplasia Punctata in a Baby Born to a Woman with Lupus Nephritis Who Received Belimumab

Mirmohd�Mosharaf�Hossain - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Lupus

Hydroxychloroquine

Treatment of Henoch-Schönlein Purpura Nephritis with Hydroxychloroquine: A Retrospective Cohort Study

YixuanPan - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Henoch-Schonlein purpura nephritis

Hydroxychloroquine

Double Trouble: Pulmonary-Renal Syndrome due to IgG4-RD and Myeloperoxidase-ANCA Vasculitis

TanujaYalamarti - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Membranous glomerulonephritis

Hydroxychloroquine

Tubular Basement Membrane Deposits in Lupus Nephritis

AnumMalik - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Lysosome: At the Crossroads Between Na+-K+-ATPase and NLRP3 in Hyperuricemia-Induced Renal Tubular Injury

JingXiao - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Tubular injury

Hydroxychloroquine

Case Study: A Report on the Efficacy of Hydroxychloroquine in Treating Hypercalcemia

SaraHammond - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Hydroxychloroquine

Venous Thromboembolism in Lupus Nephritis by ISN/RPS Biopsy Classification

IanDavidCooley - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

Hydroxychloroquine

Protective Effect of Hydroxychloroquine on Cultured Mouse Podocytes Expressing the HIV Accessory Protein Vpr

HiroshiKajiyama - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

HYDROXYCHLOROQUINE ATTENUATES RENAL ISCHEMIA REPERFUSION INJURY BY INHIBITING CATHEPSIN MEDIATED NLRP3 INFLAMMASOME ACTIVATION

Taotao Tang - European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

Hydroxychloroquine

RISK FACTORS OF PREECLAMPSIA IN PREGNANT WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Tatiana Kirsanova - European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Improved antimalarial delivery to inflammatory cells driving lupus pathogenesis using shape-based targeting nanoparticles

Marilyn Allen - American Association of Immunologists (AAI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Hydroxychloroquine enhances efferocytosis and inhibits IL-6 and TNF-α productions through upregulating both Gas6/Axl and MFG-E8/TG2 Signaling pathways in Pristine-induced lupus mice (P878)

Gregory J Tsay - American Association of Immunologists (AAI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

IV Cyclophosphamide vs Tacrolimus and Azathioprine as Induction in Proliferative Lupus Nephritis: A Randomized Controlled Trial

ArpitaRoychowdhury - American Society of Nephrology (ASN) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Simultaneous Renal Tubular Acidosis and Nephrogenic Diabetes Insipidus in a Patient with Sjogren’s Syndrome

MohamadA.Hanouneh - American Society of Nephrology (ASN) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

Hypercalcemia Secondary to Calcitriol and PTHrP Cosecretion Only Responsive to Hydroxychloroquine

Samir S Panvelker - Endocrine Society (ENDO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Diffuse large B-cell lymphoma

Hydroxychloroquine

Copyright © 2026. QuantiNova All rights reserved